Normal-appearing white matter changes in multiple sclerosis: the contribution of magnetic resonance techniques
暂无分享,去创建一个
[1] G J Barker,et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. , 1994, Brain : a journal of neurology.
[2] F. Barkhof,et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis , 1996, Annals of neurology.
[3] R. Balaban,et al. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo , 1989, Magnetic resonance in medicine.
[4] C. W. Adams,et al. Pathology of multiple sclerosis: progression of the lesion. , 1977, British medical bulletin.
[5] R I Grossman,et al. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. , 1995, Radiology.
[6] M A Horsfield,et al. Diffusion magnetic resonance imaging in multiple sclerosis. , 1998, Journal of neurology, neurosurgery, and psychiatry.
[7] D. Silberberg,et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.
[8] G. Johnson,et al. Quantitative magnetic resonance imaging in multiple sclerosis: the effect of high dose intravenous methylprednisolone. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[9] L. Laitinen,et al. Studies on the pathogenesis of multiple sclerosis. Participation of lysosomes on demyelination in the central nervous system white matter outside plaques. , 1973, European neurology.
[10] J. Vion-Dury,et al. A multiparametric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic characterization of neurological diseases , 1993, Journal of the Neurological Sciences.
[11] P. Dupont,et al. Positron emission tomography, magnetic resonance imaging and proton NMR spectroscopy of white matter in multiple sclerosis , 1997, Multiple sclerosis.
[12] P M Matthews,et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. , 1998, Brain : a journal of neurology.
[13] Moses Rodriguez,et al. Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis , 1996, Brain pathology.
[14] M Filippi,et al. Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosis , 1998, Annals of neurology.
[15] J. Olesen,et al. In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis , 1988, Magnetic resonance in medicine.
[16] L. Kappos,et al. Proton MRS of Gadolinium‐enhancing MS Plaques and Metabolic Changes in Normal‐Appearing White Matter , 1995, Magnetic resonance in medicine.
[17] A. Simmons,et al. A proton magnetic resonance spectroscopic study in ALS , 1998, Neurology.
[18] A. Compston,et al. Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. , 1996, Brain : a journal of neurology.
[19] A. Thompson,et al. Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. , 1996, Brain : a journal of neurology.
[20] G. Comi,et al. Resolution‐dependent estimates of lesion volumes in magnetic resonance imaging studies of the brain in multiple sclerosis , 1995, Annals of neurology.
[21] M. Osbakken,et al. Spin‐lattice relaxation (T1) times of cerebral white matter in multiple sclerosis , 1986, Magnetic resonance in medicine.
[22] J A Frank,et al. Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis , 1998, Annals of neurology.
[23] D. MacManus,et al. Relaxation times of apparently normal cerebral white matter in multiple sclerosis. , 1986, Acta radiologica. Supplementum.
[24] P M Matthews,et al. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques , 1992, Annals of neurology.
[25] P M Matthews,et al. Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. , 1996, Brain : a journal of neurology.
[26] P M Matthews,et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. , 1998, Brain : a journal of neurology.
[27] G. Barker,et al. Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis , 1999, Journal of the Neurological Sciences.
[28] A. Thompson,et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. , 1995, Brain : a journal of neurology.
[29] V. Haughton,et al. Quantitative MR in the diagnosis of multiple sclerosis , 1992, Magnetic resonance in medicine.
[30] R. Grossman,et al. Magnetization transfer imaging of periventricular hyperintense white matter in the elderly. , 1995, AJNR. American journal of neuroradiology.
[31] Y. Kinosada,et al. Detection of pyramidal tract lesions in amyotrophic lateral sclerosis with magnetization-transfer measurements. , 1997, AJNR. American journal of neuroradiology.
[32] G. Barker,et al. Correlation of magnetization transfer ration with clinical disability in multiple sclerosis , 1994, Annals of neurology.
[33] Massimo Filippi,et al. Brain and spinal cord MR in benign multiple sclerosis: a follow-up study , 1996, Journal of the Neurological Sciences.
[34] D Gounot,et al. In vivo determination of multiexponential T2 relaxation in the brain of patients with multiple sclerosis. , 1991, Magnetic resonance imaging.
[35] J K Udupa,et al. Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measures of lesion burden in patients with multiple sclerosis. , 1998, AJNR. American journal of neuroradiology.
[36] W. Mcdonald,et al. The pathological evolution of multiple sclerosis , 1992, Neuropathology and applied neurobiology.
[37] M Filippi,et al. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI , 1999, Neurology.
[38] M Rovaris,et al. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis , 1998, Neurology.
[39] F. Barkhof,et al. Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis , 1996, Neurology.
[40] J. Dartigues,et al. Magnetization transfer study of HIV encephalitis and progressive multifocal leukoencephalopathy. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. , 1997, AJNR. American journal of neuroradiology.
[41] I. Allen,et al. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis , 1979, Journal of the Neurological Sciences.
[42] A. Thompson,et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis , 1991, Annals of neurology.
[43] G. Fein,et al. Biochemical alterations in multiple sclerosis lesions and normal‐appearing white matter detected by in vivo 31P and 1H spectroscopic imaging , 1994, Annals of neurology.
[44] G J Barker,et al. Macroscopic and microscopic assessments of disease burden by MRI in multiple sclerosis: Relationship to clinical parameters , 1996, Journal of magnetic resonance imaging : JMRI.
[45] M W Weiner,et al. 1H MRSI of normal appearing white matter in multiple sclerosis , 1997, Multiple sclerosis.
[46] C P Langlotz,et al. MR identification of white matter abnormalities in multiple sclerosis: a comparison between 1.5 T and 4 T. , 1998, AJNR. American journal of neuroradiology.
[47] H. Bruhn,et al. Multiple sclerosis in children: Cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo , 1992, Annals of neurology.
[48] C. Thomsen,et al. Increased water self‐diffusion in chronic plaques and in apparently normal white matter in patients with multiple sclerosis , 1993, Acta neurologica Scandinavica.
[49] M Filippi,et al. Long-term changes of magnetization transfer-derived measures from patients with relapsing-remitting and secondary progressive multiple sclerosis. , 1999, AJNR. American journal of neuroradiology.
[50] A J Thompson,et al. PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS , 1997 .
[51] R H Edwards,et al. Magnetic resonance relaxation time mapping in multiple sclerosis: normal appearing white matter and the "invisible" lesion load. , 1994, Magnetic resonance imaging.
[52] Marco Rovaris,et al. Brain MRI correlates of magnetization transfer imaging metrics in patients with multiple sclerosis , 1999, Journal of the Neurological Sciences.
[53] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[54] A. Baert,et al. Human brain proton localized NMR spectroscopy in multiple sclerosis , 1991, Magnetic resonance in medicine.
[55] R. Kamman,et al. In vivo phosphorus magnetic resonance spectroscopy in multiple sclerosis. , 1992, Archives of neurology.
[56] R I Grossman,et al. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: Estimation of macroscopic and microscopic disease burden , 1996, Magnetic resonance in medicine.
[57] H. Tobi,et al. Correlating MRI and clinical disease activity in multiple sclerosis , 1995, Neurology.
[58] R E Lenkinski,et al. Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis , 1994, Magnetic resonance in medicine.
[59] M Filippi,et al. Magnetization transfer imaging of patients with definite MS and negative conventional MRI , 1999, Neurology.
[60] L. Deecke,et al. Changes within the "normal" cerebral white matter of multiple sclerosis patients during acute attacks and during high-dose cortisone therapy assessed by means of quantitative MRI. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[61] G. Barker,et al. The transverse magnetisation decay characteristics of longstanding lesions and normal-appearing white matter in multiple sclerosis , 1997, Journal of Neurology.
[62] G Johnson,et al. Precise relaxation time measurements of normal‐appearing white matter in inflammatory central nervous system disease , 1989, Magnetic resonance in medicine.
[63] G. Comi,et al. Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium , 1998, Neurology.
[64] David H. Miller,et al. Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance , 1996, Magnetic resonance in medicine.
[65] E. Cabanis,et al. In vivo localized NMR proton spectroscopy of normal appearing white matter in patients with multiple sclerosis. , 1996, Journal of neuroradiology. Journal de neuroradiologie.
[66] M. Filippi,et al. A magnetization transfer study of white matter in siblings of multiple sclerosis patients , 1997, Journal of the Neurological Sciences.
[67] J K Udupa,et al. Correlation of volumetric magnetization transfer imaging with clinical data in MS , 1998, Neurology.
[68] J S Wolinsky,et al. Serial proton magnetic resonance spectroscopic imaging, contrast‐enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis , 1998, Annals of neurology.
[69] F. Barkhof,et al. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. , 1998, Brain : a journal of neurology.
[70] G J Barker,et al. Serial magnetization transfer imaging to characterize the early evolution of new MS lesions , 1998, Neurology.
[71] D Origgi,et al. Benign versus secondary-progressive multiple sclerosis: the potential role of proton MR spectroscopy in defining the nature of disability. , 1998, AJNR. American journal of neuroradiology.
[72] M Filippi,et al. A magnetization transfer histogram study of normal-appearing brain tissue in MS , 2000, Neurology.
[73] P M Matthews,et al. Axonal dysfunction and disability in a relapse of multiple sclerosis: Longitudinal study of a patient , 1997, Neurology.
[74] G. Barker,et al. 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis , 1997, Journal of neurology, neurosurgery, and psychiatry.
[75] R E Lenkinski,et al. Proton MR spectroscopy and magnetization transfer ratio in multiple sclerosis: correlative findings of active versus irreversible plaque disease. , 1996, AJNR. American journal of neuroradiology.
[76] R I Grossman,et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. , 1992, Radiology.
[77] Hans Lassmann,et al. Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology , 1997, Annals of neurology.
[78] M Filippi,et al. A Magnetization Transfer Imaging Study of Normal-Appearing White Matter in Multiple Sclerosis , 1995, Neurology.
[79] M Filippi,et al. The role of non-conventional magnetic resonance techniques in monitoring evolution of multiple sclerosis. , 1998, Journal of neurology, neurosurgery, and psychiatry.